Susan Hockfield, Ph.D., serves as a Director at Pfizer Inc., where she brings her extensive expertise in science and technology to the company's board. As of 2020, she is an independent board member, contributing her insights to the Science and Technology Committee. Hockfield's role at Pfizer is a natural extension of her distinguished career in neuroscience and leadership in academic and public service roles.

Hockfield's professional journey is marked by several notable achievements. She made history as the first woman and first life scientist to serve as President of the Massachusetts Institute of Technology (MIT) from 2004 to 2012. Prior to her tenure at MIT, she held significant positions at Yale University, including Dean of the Graduate School of Arts and Sciences, Provost, and Professor of Neuroscience. Her academic contributions extend beyond these roles, as she has also served as a Professor of Neuroscience at MIT. Hockfield's commitment to advancing scientific research and education is evident in her public service as a Science Envoy with the U.S. Department of State, where she worked to strengthen international collaborations in science and technology.

In addition to her role at Pfizer, Hockfield serves on the boards of Repertoire Immune Medicines and Cajal Neuroscience, further demonstrating her dedication to the life sciences industry. She was also the founding co-chair of the Advanced Manufacturing Partnership, an initiative aimed at enhancing U.S. competitiveness in manufacturing. Hockfield's contributions to the scientific community have been recognized through her election as a Fellow of the American Association for the Advancement of Science. With her wealth of experience and leadership in science and technology, Susan Hockfield continues to play a vital role in shaping the future of healthcare and innovation at Pfizer and beyond.